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Abstract
Background: The prognostic role of low postoperative serum albumin levels (SAL) after cardiac surgery (CS)
remains unclear in patients with normal preoperative SAL. Our aim was to evaluate the influence of SAL on the
outcome of CS.
Methods: Prospective observational study. Patients undergoing CS with normal preoperative SAL and nutritional
status were included and classified into different subgroups based on SAL at 24 h after CS. We assessed outcomes
(i.e., in-hospital mortality, postoperative complications and long-term survival) and results were analyzed among the
different subgroups of SAL.
Results: We included 2818 patients. Mean age was 64.5 ± 11.6 years and body mass index 28.0 ± 4.3Kg·m− 2.
5.8%(n = 162) of the patients had normal SAL levels(≥35 g·L− 1), 32.8%(n = 924) low deficit (30–34.9 g·L− 1),
44.3%(n = 1249) moderate deficit (25–29.9 g·L− 1), and 17.1%(n = 483) severe deficit(< 25 g·L− 1). Higher SAL after
CS was associated with reduced in-hospital (OR:0.84;95% CI:0.80–0.84; P = 0.007) and long-term mortality (HR:
0.85;95% CI:0.82–0.87;P < 0.001). Subgroups of patients with lower SAL showed worst long-term survival (5-year
mortality:94.3% normal subgroup, 87.4% low, 83.1% moderate and 72.4% severe;P < 0.001). Multivariable
analysis showed higher in-hospital mortality, sepsis, hemorrhage related complications, and ICU stay in
subgroups of patients with lower SAL. Predictors of moderate and severe hypoalbuminemia were preoperative
chronic kidney disease, previous CS, and longer cardiopulmonary bypass time.
Conclusions: The presence of postoperative hypoalbuminemia after CS is frequent and the degree of
hypoalbuminemia may be associated with worst outcomes, even in the long-term scenario.
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Background
Liver proteins, such as albumin, have been considered
over time as indicators of morbidity and mortality, as
well as recovery markers of acute and chronic disease
[1]. Serum levels may identify patients most likely to
develop malnutrition or with a previous poor nutri-
tional status, even when adequate nutritional supple-
mentations during hospital stay is being performed
[1]. Indeed, recent published guidelines suggest that
surgery should be avoided in patients with low pre-
operative serum albumin levels (SAL) (< 30 g∙L− 1) due
to its association with worst outcomes and impaired
nutritional status [2].
Low preoperative SAL are associated with compli-
cations and mortality in the setting of cardiac sur-
gery (CS) in patients who underwent coronary
artery bypass graft (CABG), as well as other an-
thropometric values associated with nutritional sta-
tus, such as body mass index (BMI) [3]. However,
no correlation between low BMI (< 20 kg∙m− 2) and
low SAL (< 25 g∙L− 1) has been reported [4]. Further-
more, SAL has been considered as an independent
prognosis marker in several studies related with CS
procedures, even in the setting of newer technology,
such as transcatheter aortic valve replacement and
left-ventricular assist device [5–7]. The level of hy-
poalbuminemia required to increase the risk of
these outcomes has not been properly defined and
varies depending on the study (i.e., under 20, 35 or
40 g∙L− 1) [8–10]. Increased risk of postoperative in-
fection in patients with low preoperative SAL has
also been reported [11].
The presence of low postoperative SAL after CS
may be caused by several factors apart from low pre-
operative SAL, which include surgical injury, dilution
due to fluid resuscitation, blood loss and cardiopul-
monary bypass (CPB) among other factors [12]. The
associated underlying pathophysiological mechanism is
mainly related with the degree of ischemia-
reperfusion injury or systemic inflammatory response
syndrome (SIRS) produced during CS and a higher
degree of SIRS is associated with higher risk of mor-
bidities and mortality [13]. However, excessive fluid
reanimation and blood loss can also influence in the
occurrence of lower postoperative SAL [12]. Thus,
postoperative hypoalbuminemia is the summation of
different factors associated with outcomes after CS
and postoperative SAL may have prognosis
implications.
It is well known that the early identification of pa-
tients at risk for poor outcome after CS may be
helpful in modifying patient care strategy in the In-
tensive Care Unit (ICU) in order to improve out-
comes. A better understanding of the different
aspects that contribute to morbidity and mortality is
needed because CS population trend towards aging
and an increasing incidence of comorbidities which
ultimately affects the frailty of these patients [14]. In
addition, measuring long-term outcomes is a marker
of the quality of perioperative care in CS [15]. Moni-
toring of postoperative SAL may be a helpful tool
for risk stratification and prognosis assessment due
to the different cumulative aspects that SAL entails
(e.g., inflammatory response, fluid status and malnu-
trition) [12]. The aim of the present study was to
evaluate the influence of postoperative SAL on the
short- and long-term outcomes of patients who
underwent CS with normal preoperative SAL. We
also aimed to identify those factors related with
postoperative moderate to severe hypoalbuminemia
(< 30 g∙L− 1).
Methods
A prospective observational study was performed in a
surgical Intensive Care Unit (ICU) of a university af-
filiated referral hospital between June 2006 and Sep-
tember 2011. All consecutive patients undergoing
different types of CS with preoperative normal albu-
min levels (i.e., SAL > 35 g∙L− 1) and appropriate nutri-
tional status (evaluated by means of Subjective Global
Assessment) were considered for the study. Heart-
transplant patients were excluded due to the potential
influence of immunosuppressant and/or corticosteroid
therapy over postoperative SAL and inflammatory re-
sponse (see Supplementary Figure 1). The study was
approved by the Institutional Ethics Committee of
our hospital (Comité d’Ètica i Assajos Clínics de Hos-
pital Universitari de Bellvitge; Barcelona, Spain); with
approval number 39/07. Informed consent was waived
due to the observational nature of our study (Details
of the ethics approval and study protocol are pro-
vided as supplementary material).
Data were prospectively extracted from the medical
registry of each patient and collected in a local data-
base for analysis purposes. Preoperative data (demo-
graphic data, comorbidities and treatment before
surgery), operative data and postoperative variables
were routinely collected together with CS scores (Par-
sonnet, European System for Cardiac Operative Risk
Evaluation (EuroSCORE)) and ICU scores (Acute
Physiology and Chronic Health Evaluation (APACHE)
II and III, Simplified Acute Physiology Score (SAPS)
II and III). A follow-up during 4.6 ± 2.4 years was per-
formed in 2565 patients (Follow-up was not possible
in 94 patients that were alive at hospital discharge).
The long-term follow-up was performed using the
Catalan Health Central Registry (Registre Central de
Persones Assegurades).
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Table 1 Preoperative (A), intraoperative and postoperative (B) characteristics of the population
A All patients (n = 2818) Hospital Survivors
(n = 2659; 94.4%)
Non-survivors
(n = 159; 5.6%)
P
Preoperative data
Age (years) 64.5 ± 11.6 64.2 ± 11.6 69.7 ± 10 < 0.001
Sex (male) 63.8% (1799) 63.7% (1696) 64.7%(103) 0.86
BMI (Kg·m−2) 28.0 ± 4.3 27.9 ± 4.3 28.0 ± 4.6 0.89
Albumin before surgery (g ·L−1) 40.0 ± 3.5 40.1 ± 2.8 39.9 ± 1.5 0.85
Subjective Global Assessment (class B) 5.8% (163) 5.9% (158) 3.1% (5) 0.25
Hypertension 62.7% (1768) 62.1% (1650) 74.2%(118) 0.002
Diabetes Mellitus 24.8% (699) 24.9% (662) 33.3% (53) 0.03
Dyslipidemia 50.5% (1423) 50.4%(1339) 52.8% (84) 0.56
Peripheral vascular disease 8.8% (249) 8.3% (220) 18.2% (29) < 0.001
Chronic renal insufficiency 5.2% (146) 4.6% (122) 15.1%(24) < 0.001
Renal failure (on Dialysis) 0.8% (23) 0.8% (20) 1.9%(3) 0.14
Creatinine before surgery (μmol·l−1) 96 ± 59 94 ± 58 119 ± 67 < 0.001
Previous stroke 5.6% (158) 5.5% (145) 8.2% (13) 0.15
COPD 12% (337) 11.5%(307) 18.9%(30) 0.008
Active smokers 15.5% (437) 15.3%(407) 18.8%(30) 0.58
Previous atrial fibrillation 23.8% (671) 23.3%(620) 32.8%(51) 0.005
Previous myocardial infarction 15.5% (437) 15.3% (407) 18.9% (30) 0.26
Recent myocardial infarction 11% (310) 10.5% (278) 20.1% (32) 0.001
On B-Blockers 41.3% (1165) 41.4% (1102) 39.6% (63) 0.68
On statins 41.2% (1160) 41.3% (1097) 39.6% (63) 0.74
On Aspirin 44.5% (1184) 44.5% (1184) 43.4% (69) 0.81
On diuretics 47.6% (1340) 46.6% (1239) 63.5% (101) 0.001
Hypertrophic cardiomyopathy 31.2% (880) 31% (826) 33.9% (54) 0.59
Dilated cardiomyopathy 20.4% (577) 20.2% (537) 25.1% (40) 0.19
LVEF (%) 60 ± 12 59 ± 13 60 ± 12 0.25
PAP (mmHg) 46 ± 16 45 ± 15 49 ± 16 0.04
Hemoglobin before surgery (g·dL−1) 13.0 ± 1.7 13.0 ± 1.7 12.0 ± 1.9 0.001
Platelet count before surgery (1·nl− 1) 215 ± 68 216 ± 68 208 ± 75 0.24
Emergent surgery 5.1% (143) 4.5% (120) 14.5% (23) < 0.001
Past cardiac surgery 9.4% (266) 9.2% (245) 13.2% (21) 0.09
EuroSCORE 5.9 ± 3 5.7 ± 2.8 8.6 ± 3.8 < 0.001
Parsonnet score 11.4 ± 7.4 11.2 ± 7.2 15.4 ± 9.8 < 0.001
B All patients (n = 2818) Hospital
Survivors
(n = 2659; 94.4%)
Non-survivors
(n = 159; 5.6%)
P
Intraoperative data
Isolated CABG 32.2% (907) 32.3% (859) 30.2% (48) 0.86
Isolated valve surgery 51.7% (1456) 52% (1382) 46.5% (74) 0.65
CABG + valve surgery 6.9% (194) 6.7% (178) 10.1% (16) 0.09
Other cardiac surgery 9.2% (261) 9% (240) 13.2% (21) 0.06
Number of bypass 3 (2–4) 3 (2–4) 3 (2–4) 0.85
CPB time (min) 112 ± 41 111 ± 39 140 ± 62 0.001
ACC time (min) 74 ± 30 73 ± 29 84 ± 37 0.001
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Postoperative SAL was measured 24 h after CS and pa-
tients were classified into different categories based on
local laboratory categories of SAL and previous research
[4, 6]: normal (≥35 g∙L− 1) (n = 162), low deficit (30–34.9
g∙L− 1) (n = 924), mild deficit (25–29.9 g∙L− 1) (n = 1249)
and severe deficit (< 25 g∙L− 1) (n = 483). We chose 24 h
postoperative for measuring SAL because based on our
clinical experience unstable patients received usually
major part of fluid resuscitation and blood products
from ICU admission to 24 h, which may alter SAL the
most, and because 24 h is the timeline used in ICU for
prognosis assessment [16].
Recent acute myocardial infarction (AMI) was defined as
an AMI that required admission to the hospital during the
last month before surgery or an AMI that did not allow dis-
charge from the hospital before surgery. The other defini-
tions used for this study were based on the Society of
Thoracic Surgeons’ national CS database definitions [17].
The operations were performed by the same group
of surgeons during the study period following stan-
dards of practice. The priming fluid for the CPB sys-
tem were crystalloids during the study period with a
priming volume of the circuit between 500 and 800
mL. In all patients, decisions regarding perioperative
management were made by the attending physician
according to local protocols. Patients were treated ac-
cording to hemodynamic parameters and metabolic
markers of tissue perfusion, such as arterial lactate
Table 1 Preoperative (A), intraoperative and postoperative (B) characteristics of the population (Continued)
Postoperative data
APACHE II 12.3 ± 4.6 11.8 ± 4.1 19 ± 6.8 < 0.001
APACHE III 50 ± 18.3 48.2 ± 16 78.1 ± 27.8 < 0.001
SAPS II 24 ± 9.6 23.3 ± 8.4 38 ± 14.6 < 0.001
SAPS III 40.0 ± 10.4 39.3 ± 9.6 51.8 ± 13.5 < 0.001
Ventilation time (hours) 51 ± 129 39 ± 99 248 ± 309 < 0.001
PaO2/FiO2 ratio on admission 331 ± 98 333 ± 97 290 ± 112 < 0.001
PaO2/FiO2 ratio 12 h after admission 311 ± 89 315 ± 87 249 ± 98 < 0.001
PaO2/FiO2 ratio 24 h after admission 308 ± 76 312 ± 73 236 ± 92 < 0.001
Reintubation 1.1% (31) 1% (25) 3.8% (6) 0.01
Tracheostomy 1.3% (35) 1% (26) 5.7% (9) 0.005
Need of vasoactive drugs (hours) 103 ± 141 91 ± 116 253 ± 271 < 0.001
LCOS 41.5% (1170) 38.8% (1034) 85.5% (136) < 0.001
PMI 11.6% (327) 10.2% (272) 34.6% (55) < 0.001
IABP support 7.8% (222) 6.7% (180) 26.4% (42) < 0.001
Atrial Fibrilation 39.5% (1114) 37.9% (1009) 66% (105) < 0.001
Albumin 24 h after surgery (g ·L−1) 28 ± 4.8 28 ± 2.4 25 ± 3.5 < 0.001
AL peak after surgery (mmol·l−1) 3.8 ± 1.8 3.6 ± 1.4 5.9 ± 4.3 < 0.001
Acute Renal Failure 9.7% (272) 6.5% (174) 61.6% (98) < 0.001
Need for RRT 2.1% (58) 0.8% (22) 22.6% (36) < 0.001
Haemorrhage-related reexploration 3.4% (97) 3% (81) 10.1% (16) < 0.001
Pericardial tamponade 0.7% (19) 0.6% (17) 1.3% (2) 0.29
Drainage loss first 12 h (ml) 392 ± 295 386 ± 287 492 ± 398 < 0.001
Re-exploration 1.6% (47) 1.1% (30) 10.7% (17) < 0.001
Need for blood products first 24 h (Units) 1.2 ± 1.9 1.1 ± 1.6 3.2 ± 3.9 0.01
Stroke 1.4% (39) 1.1% (28) 6.9% (11) < 0.001
Septicaemia 6.6% (186) 4.6% (122) 40.2% (65) < 0.001
Mean ICU stay (hours) 125 ± 158 114 ± 131 301 ± 314 0.003
Mean hospital stay (days) 25.0 ± 20.3 22.3 ± 18.3 36.4 ± 58.2 < 0.001
BMI Body Mass Index, COPD Chronic Obstructive Pulmonary Disease, NYHA New York Heart Association classification, LVEF Left ventricular ejection fraction, PAP
Pulmonary arterial pressure, EuroSCORE European system for cardiac operative risk evaluation, CABG coronary artery bypass graft, CPB Cardiopulmonary Bypass,
ACC Aortic cross clamping, APACHE Acute Physiology and Chronic Health Evaluation, SAPS Simplified Acute Physiology Score, PaO2/FiO2 Arterial partial pressure of
O2 and fraction of inspired oxygen ratio, LCOS Low Cardiac Output Syndrome, PMI Perioperative Myocardial Infarction, IABP intra-aortic balloon pump, AL Arterial
Lactate, RRT Renal Replacement Therapy. Results are expressed as mean ± standard deviation, percentage or median and interquartile range
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levels and venous oxygen saturation. Fluid resuscita-
tion was performed based on local protocol following
a restricted fluid regimen in order to avoid excessive
positive fluid balance (i.e., > 2 L of positive fluid bal-
ance per day) [18]. Our hemodynamic objectives were
to achieve both appropriate mean arterial pressure
(MAP) (i.e., about 70 mmHg or the previously re-
ported usual MAP in each patient) and urine output
(i.e., > 0.5 mL·Kg− 1·h− 1 or higher to avoid positive
fluid balance). Global end-diastolic volume index
(about 680–800 mL·m− 2) or cardiac index (about 2.5
L·min− 1·m− 2) were also monitored in the presence of
high dose of vasopressors or inotropes [19]. We mon-
itored central venous pressure to see the dynamic
changes over time and fluid responsiveness to passive
leg raise in conjunction with previous clinical evalu-
ation for hemodynamic management [19]. Fluid load-
ing was performed by crystalloids. According with our
previous research, our perioperative transfusion trig-
ger is hemoglobin value between 7 and 8 g·dL− 1 with
a targeted hematocrit on CPB about 21–24% [20].
Transfusions occurring during fist 24 h were assessed
due to the potential influence over SAL. Supplemental
albumin administration was not specifically forbidden
but none was administered to any patient during the
study period. A glycemic protocol was applied during
and after CS based on local protocols in order to
avoid blood glucose levels > 180 mg·dL− 1 during and/
or after CS.
Statistical analyses
Statistical analysis was conducted using PASW statis-
tics 20.0 (SPSS Inc., Chicago, Illinois, USA). Data are
expressed as mean ± standard deviation or median
(interquartile range) as appropriate. In order to evalu-
ate the association of postoperative SAL with
mortality after CS, we analyzed differences between
survivors and non-survivors with univariate analyses
(for comparisons between groups the Mann-Whitney
U test was used or, when appropriate, the two-sample
t-test; the χ2-test was used to evaluate categorical
prognostic factors) to identify the importance of post-
operative SAL as a factor associated with mortality.
ANOVA was used to compare differences in charac-
teristics and outcome between different hypoalbumin-
emia subgroups (P values shown in tables) and
subsequent post hoc tests (Bonferroni tests) were
used to determine and confirm significant differences
in the various pairwise comparisons (P values shown
in results section).
Multivariate analysis was carried out using a backward
stepwise logistic regression to identify predictors of in-
hospital mortality after CS. Variables with P < 0.1 were
included in the initial model and according the criteria
of the investigators (i.e., redundant and associated vari-
ables were avoided). Change-in-estimates criterion and
backwards deletion with a 10% cutoff was used to elim-
inate confounding variables from our final models. Pro-
portional Hazards Cox regression model was used to
evaluate predictors of long-term mortality after adjusting
for the time of follow-up period.
We tested for interactions between the variables that we
introduced into all the multivariate analyses, in order to
avoid destabilization of the different analyses. We per-
formed adjustment for age, preoperative albumin, type of
cardiac surgery, CPB time, EuroSCORE and the significant
preoperative differences between the subgroups in order to
avoid the influence of the severity of illness when outcomes
were analyzed. Finally, we also analyze using the same stat-
istical methods preoperative and intraoperative variables in
order to show factors associated with the occurrence of
postoperative moderate to severe hypoalbuminemia.
Table 2 Multivariate analysis – variables associated with in-hospital and long-term mortality
Dependent variable in-hospital mortality Odds ratio
(95% Confidence Interval)
P-value
Age 1.050 (1.027–1.075) < 0.001
Cardiopulmonary bypass time (> 100min) 1.007 (1.003–1.010) 0.001
Albumin 24 h after surgery (g·L−1) 0.844 (0.805–0.844) 0.007
Dependent variable long-term mortality Hazards ratio
(95% Confidence Interval)
P-value
Age 1.063 (1.049–1.076) < 0.001
Cardiopulmonary bypass time (> 100min) 1.004 (1.002–1.006) 0.001
Dilated cardiomyopathy 1.435 (1.139–1.810) 0.002
Albumin 24 h after surgery (g·L−1) 0.846 (0.821–0.871) < 0.001
Acute Renal Failure 2.523 (1.395–2.933) < 0.001
Low Cardiac Output Syndrome 1.489 (1.276–1.656) 0.006
Septicaemia 1.125 (1.018–1.696) 0.02
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In all cases, the Kolmogorov-Smirnov test and
D’Agostino-Pearson omnibus normality test were used
to check the normal distribution of our population
and to assess the goodness-of-fit of the final regres-
sion models. Survival analysis was carried out using
the Kaplan-Meier estimator for the different
Fig. 1 Kaplan-Meier survival curves based on subgroups of patients with different albumin levels 24 h after cardiac surgery including in-hospital
mortality (a) and only with hospital survivors (b)
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hypoalbuminemia subgroups. Proportional Hazards
Cox regression model was used to confirm survival
analysis, which was risk-adjusted in order to avoid
the severity of illness. Two-tailed P value < 0.05 was
considered statistically significant.
Results
Baseline characteristics and postoperative SAL as a factor
associated with mortality and survival
Patients were 2818 and overall they had a hospital
mortality of 5.6%. Characteristics of our studied popu-
lation are provided in Table 1. Preoperative, intraop-
erative and postoperative data comparing survivors
and non-survivors showed that non-survivors were
older, underwent longer CPB during CS, had lower
SAL and higher rates of morbidities and postoperative
complications (see Table 1). Multivariate analysis
showed that lower levels of SAL (i.e., SAL as absolute
value) were both associated with increased in-hospital
(Odds ratio (OR): 0.844, 95% confidence interval (CI)
0.805 to 0.844, P = 0.007) and long-term mortality
(Hazard ratio (HR): 0.846, 95% CI 0.821 to 0.871, P <
0.001). Other variables, such as older age, having a di-
lated cardiomyopathy in the preoperative echocardiog-
raphy, suffering a CPB > 100 min, suffering from
postoperative acute renal failure, low cardiac output
syndrome and sepsis during the postoperative period,
were also associated with mortality (Table 2; see Sup-
plementary Table 1 for full model results).
A follow-up was performed in all patients for in-
hospital mortality in 2659 patients with a mean
follow-up of 4.6 ± 2.4 years. There was shown a
lower survival rate and higher mortality over time
in patients with lower SAL, and particularly in the
severe albumin deficit group (Fig. 1 and Table 3).
Additional analyses showed that normal SAL (≥35
g∙L− 1) was associated with better in-hospital survival
(HR = 0.570, 95% CI 0.388 to 0.836, P = 0.004) and
long term survival (HR = 0.315, 95% CI 0.145 to
0.682, P = 0.003) whereas moderate (25–29.9 g∙L− 1)
(HR = 1.604, 95% CI 1.452 to 1.806, P = 0.001) and
severe deficits (< 25 g∙L− 1) (HR = 1.966, 95% CI
1.520 to 2.853, P = 0.001) were independent risk fac-
tors for increased long-term mortality. The relation-
ship between postoperative SAL and in-hospital
mortality was not linear and progressively higher
among subgroups depending on the severity of hy-
poalbuminemia, as showed by Fig. 2.
Differences between postoperative SAL subgroups and
risk factors for hypoalbuminemia
When we compared between postoperative SAL
subgroups (P from ANOVA test provided in
Table 4), preoperative variables showed older pa-
tients, higher cardiovascular risk factors (such as
hypertension, dyslipidemia and diabetes mellitus)
and an increased prevalence of chronic renal insuf-
ficiency in low SAL determination groups (Bonfer-
roni post hoc test; P < 0.001). In addition, there was
subgroup differences in hemoglobin determinations
before surgery (P = 0.001). Patients with severe SAL
deficit required longer CPB and aortic cross clamp-
ing (ACC) times compared with the other groups
(P < 0.001). Postoperative variables showed longer
ventilation time and vasoactive drug requirements
for low SAL subgroups (P < 0.001) and a higher
acute renal failure incidence in the severe SAL def-
icit group when compared with other subgroups
(P < 0.001). Mean ICU and hospital stay was higher
for the low SAL determination groups, especially in
the severe deficit group (P < 0.001). In-hospital mor-
tality was also higher in this group when compared
to others (P < 0.001).
All these findings regarding the differences in out-
comes between the SAL subgroups from the univariate
analysis were analyzed by means of multivariate analysis.
A higher mortality rate, longer ICU stay and higher inci-
dence of bleeding and sepsis-related complications were
Table 3 Long-term mortality based on subgroups of patients with different albumin levels 24 h after cardiac surgery including all
patients (A) and only with hospital survivors (B)
A In-hospital survival 1-year survival 3-year survival 5-year survival
Normal Levels (≥35 g·L−1) 98.1% 98.1% 96.5% 94.3%
Low deficit (30–34.9 g·L−1) 97.3% 94.2% 89.2% 87.4%
Mild deficit (25–29.9 g·L−1) 95% 91.5% 86.1% 83.1%
Severe deficit (< 25 g·L−1) 85.9% 78.3% 74.5% 72.4%
B
Normal Levels (≥35 g·L−1) 100% 98.9% 97.8% 96.2%
Low deficit (30–34.9 g·L−1) 100% 97.9% 94.2% 89.9%
Mild deficit (25–29.9 g·L−1) 100% 96.8% 92.3% 87.7%
Severe deficit (< 25 g·L−1) 100% 95.1% 87.5% 84.8%
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associated with lower levels of postoperative SAL when
we made comparisons between the different postopera-
tive SAL subgroups (Table 5; see Supplementary Table 2
for full model results).
We also identified an association between chronic
renal insufficiency, past CS and longer CPB times with
the presence of mild to severe degree of hypoalbuminae-
mia at 24 h after CS (Table 6; see Supplementary Table 3
for full model results).
Discussion
The most important finding of the current study is the
association of postoperative hypoalbuminemia with
worst outcomes after CS depending on its intensity, even
with influence in long-term scenario. To the best of our
knowledge this is the only prospective study addressing
the role of postoperative SAL in most types of CS proce-
dures under the effect of CPB, even those with moderate
to high complexity [12].
We excluded patients with low preoperative SAL be-
cause this may reflect a poor nutritional status that in-
fluences our results [2]. Several studies used different
preoperative values as markers, making it difficult to de-
termine a specific point to correlate these levels and a
repercussion over time [8–10]. Despite the different
values considered among these studies, it has been
Fig. 2 Relationship between in-hospital mortality rates and postoperative Serum Albumin Levels based on subgroups (a) and degree of
hypoalbuminemia (b)
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Table 4 Preoperative (A), intraoperative and postoperative (B) variables of subgroups of patients with different albumin levels 24 h
after cardiac surgery








(25–29.9 g ·L− 1)
n = 1249
44.3%





Sex (male) 75% (122) 68% (634) 61% (765) 57% (278) 0.001
Age (years) 57 ± 14.1 63 ± 11.6 65.5 ± 11.2 67.7 ± 10 < 0.001
Albumin before surgery (g ·L-1) 41 ± 2.5 41 ± 2.8 39 ± 2.9 39 ± 2.2 0.78
Subjective Global Assessment (class B) 6.1% (10) 5.9% (55) 58.8% (73) 5.1% (25) 0.89
Hypertension 53.0% (86) 60.4% (558) 63.4% (792) 68.7% (332) 0.001
Dyslipidemia 42.0% (68) 47.6% (440) 53.1% (663) 52.2% (252) 0.009
Diabetes Mellitus 19.1% (31) 24.3% (225) 26.1% (327) 27.1% (131) 0.06
BMI (kg·m−2) 27.6 ± 4.6 28.3 ± 4.2 27.9 ± 4.2 27.4 ± 4.3 0.90
Peripheral vascular disease 3.7% (6) 6.8% (63) 10.2% (127) 11% (53) 0.001
Chronic renal insufficiency 2.5% (4) 2.9% (27) 5.2% (65) 10.4% (50) < 0.001
Renal Failure (on Dialysis) 0.6% (1) 0.4% (4) 0.7% (9) 1.9% (9) 0.04
Creatinine before surgery (μmol·l−1) 86 ± 36 88 ± 34 96 ± 61 110 ± 84 0.001
Previous Stroke 2.5% (4) 5.4% (50) 5.4% (68) 7.5% (36) 0.99
COPD 8% (13) 11.8% (109) 12.4% (155) 12.4% (60) 0.43
Active smokers 19.1% (31) 15.9% (147) 14.9% (187) 14.9% (72) 0.42
Previous Atrial Fibrillation 25.9% (42) 24% (222) 23% (288) 24.6% (119) 0.59
Previous Myocardial Infarction 14.2% (23) 14.7% (136) 16% (200) 16.1% (78) 0.79
Recent Myocardial Infarction 4.9% (8) 7.7% (71) 11.8% (148) 17.2% (83) 0.001
On B-Blockers 34.6% (56) 41.2% (381) 41.6% (520) 43.1% (208) 0.82
On statins 30.2% (49) 40.3% (372) 43.3% (541) 41% (198) 0.01
On Aspirin 28.4% (46) 42.2% (390) 47.6% (594) 46.2% (223) 0.001
On diuretics 47.5% (77) 45.1% (417) 48.7% (608) 49.3% (238) 0.33
Hypertrophic cardiomyopathy 27.1% (44) 31.6% (292) 32.9% (412) 27.3% (132) 0.11
Dilated cardiomyopathy 27.1% (44) 23% (213) 19.3% (242) 16.1% (78) 0.02
LVEF (%) 60 (48–72) 61 (47–75) 60 (41–79) 60 (43–77) 0.34
PAP (mmHg) 48 (37–59) 32 (21–43) 37 (21–53) 35 (18–52) 0.26
Hemoglobin before surgery (g·dL−1) 13.5 ± 1.5 13.3 ± 1.6 12.9 ± 1.7 12.4 ± 1.8 0.001
Platelet count before surgery (1·nL− 1) 203 ± 49 213 ± 67 215 ± 68 224 ± 75 0.002
Past Cardiac surgery 12.3% (20) 9.4% (87) 9.1% (114) 9.3% (45) 0.62
Emergent Surgery 0.6% (1) 0.9% (8) 4.6% (58) 15.7% (76) < 0.001
EuroSCORE 5.2 ± 3.2 5.7 ± 2.8 6.2 ± 1.9 7.3 ± 3.2 0.14
Parsonnet score 11.0 ± 6.2 11.1 ± 5.2 12.8 ± 3.7 13.4 ± 2.8 0.25






(30–34.9 g ·L− 1)
n = 924
32.8%
Mild deficit (25–29.9 g ·L− 1)
n = 1249
44.3%






Isolated CABG 20.4% (33) 32.3% (298) 32.5% (406) 35.2% (170) 0.001
Isolated valve surgery 64.2% (104) 56.5% (522) 50% (624) 42.7% (206) 0.001
CABG + valve surgery 3.1% (5) 4.9% (45) 8.6% (107) 7.7% (37) 0.001
Other cardiac surgery 12.3% (20) 6.4% (59) 9% (112) 14.5% (70) 0.001
Number of bypass 2 (2–3) 2 (2–3) 2 (2–3) 2 (2–4) 0.85
CPB time (min) 95 ± 39 105 ± 35 114 ± 41 127 ± 47 < 0.001
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shown that patients with low preoperative SAL have an
increased risk of morbidities and mortality after surgery
[5–11]. The need for reoperation due to bleeding has
been shown to be over 32% and mortality about 36.2%
in patients with low SAL [3]. Preoperative SAL< 25 g∙L− 1
has been associated with higher mortality risk (OR 2.0;
95% CI, 1.3–3.0; P = 0.002) and a higher reoperation for
bleeding [4]. In addition, preoperative SAL< 30 g∙L− 1 has
been related with a prolonged ICU and in-hospital stay
and a higher mortality compared with patients present-
ing normal SAL, as an independent risk factor [21]. Over
the years, albumin has been considered as a negative
acute-phase protein and a marker of inflammation [1],
but it has not been taken into consideration to predict
worse outcomes and mortality as a postoperative factor
in CS. Since 1988, when it was first reported an in-
creased risk of complications and prolonged hospital
stay in elderly patients who presented preoperative low
SAL [22], many other studies have been performed after-
wards analyzing preoperative SAL [8–10]. Some studies
have been performed showing altered protein metabol-
ism after CS procedures, such as CABG, but no one took
into consideration postoperative levels [23].
Patients undergoing CS develop a certain degree of
SIRS depending on the CPB duration required during
the intervention and other factors, such as hypothermia
Table 4 Preoperative (A), intraoperative and postoperative (B) variables of subgroups of patients with different albumin levels 24 h
after cardiac surgery (Continued)
ACC time (min) 65 ± 30 69 ± 27 75 ± 29 81 ± 32 < 0.001
Postoperative data
APACHE II 12.2 ± 2.2 11.9 ± 3.1 12.5 ± 5.8 12.9 ± 4.3 0.15
APACHE III 53.1 ± 17.9 49.2 ± 11.5 68.1 ± 20.6 75.9 ± 26.8 < 0.001
SAPS II 24 ± 8.6 22.3 ± 8.2 25.8 ± 12.4 28.2 ± 14.6 0.01
SAPS III 39.5 ± 8.4 38.2 ± 8.5 43.2 ± 10.5 45.3 ± 12.6 < 0.001
Ventilation time (hours) 6 (4–8) 19.5 (11.5–30.5) 18 (0–72) 21 (0–242) < 0.001
PaO2/FiO2 ratio on admission 323 ± 91 330 ± 95 336 ± 96 319 ± 110 0.21
PaO2/FiO2 ratio 12 h after admission 338 ± 87 319 ± 83 310 ± 90 290 ± 95 < 0.001
PaO2/FiO2 ratio 24 h after admission 328 ± 72 318 ± 67 306 ± 76 284 ± 89 < 0.001
Reintubation 0 0.5% (5) 1.6% (20) 1.2% (6) 0.10
Tracheostomy 0.6% (1) 0.6% (6) 1.1% (14) 2.8% (14) 0.09
AL peak after surgery (mmol·l−1) 3.5 ± 1.3 3.7 ± 1.7 3.7 ± 1.7 4.2 ± 2.3 0.001
Need of vasoactive drugs (hours) 67 ± 92 75 ± 112 101 ± 139 152 ± 173 < 0.001
LCOS 17.3% (28) 28.3% (262) 44.9% (562) 65.8% (318) < 0.001
PMI 8% (13) 9.1% (84) 11.8% (147) 17.2% (83) < 0.001
IABP support 0.6% (1) 4.3% (40) 7.4% (93) 18.2% (88) 0.001
Atrial Fibrillation 33.3% (54) 34.4% (318) 40.3% (503) 49.5% (239) 0.001
Acute Renal Failure 3.1% (5) 4.4% (41) 9.7% (121) 21.7% (105) < 0.001
Need for RRT 0 0.4% (4) 1.8% (22) 6.6% (32) < 0.001
Haemorrhage-related reexploration 0 1.3% (12) 4.2% (52) 6.8% (33) 0.001
Pericardial tamponade 0 0.2% (2) 0.9% (11) 1.2% (6) 0.07
Drainage loss first 12 h (ml) 307 ± 163 355 ± 255 399 ± 298 472 ± 369 0.33
Re-exploration 1.2% (2) 0.5% (5) 1.8% (23) 3.2% (17) 0.07
Need for blood products first 24 h (Units) 1 (0–2) 1 (0–6) 1 (0–3) 1 (0–4) 0.08
Stroke 0.6% (1) 1% (9) 1.8% (22) 1.4% (7) 0.38
Septicaemia 2.4% (4) 3.1% (29) 6.4% (81) 14.9% (72) < 0.001
Mean ICU stay (hours) 158 ± 213 190 ± 270 274 ± 315 327 ± 377 0.001
Mean hospital stay (days) 18 ± 11 21 ± 14 26 ± 21 33 ± 30 0.001
In-hospital mortality 1.9% (3) 2.7% (25) 5% (63) 14.1% (68) < 0.001
BMI Body Mass Index, COPD Chronic Obstructive Pulmonary Disease, NYHA New York Heart Association classification, LVEF Left ventricular ejection
fraction, PAP Pulmonary arterial pressure; EuroSCORE European system for cardiac operative risk evaluation, CABG coronary artery bypass graft; CPB
cardiopulmonary bypass, ACC Aortic cross clamping, APACHE Acute Physiology and Chronic Health Evaluation, SAPS Simplified Acute Physiology Score,
PaO2/FiO2 Arterial partial pressure of O2 and fraction of inspired oxygen ratio, LCOS Low Cardiac Output Syndrome, PMI Perioperative Myocardial
Infarction, IABP intra-aortic balloon pump, AL Arterial Lactate, RRT Renal Replacement Therapy. Results are expressed as mean ± standard deviation,
percentage or median and interquartile range
Berbel-Franco et al. Journal of Cardiothoracic Surgery           (2020) 15:78 Page 10 of 13
and blood transfusions, which may ultimately lead to the
use of vasopressor drugs [12, 13]. Under this inflamma-
tory condition, vital organs, such as the liver or kidneys,
can worsen their function due to cellular damage, an in-
creased vasodilation and extracapillar filtration leading
to a loss of albumin to the extravascular space [24]. Fol-
lowing to this process, an increased fractional synthesis
of albumin appears, stimulated by a lower oncotic pres-
sure [24]. As a result, it is not surprising that the major-
ity of our patients developed some degree of
postoperative lower SAL.
On the other hand, postoperative SAL and their impli-
cations have been studied in other clinical contexts such
as sepsis and acute kidney injury (AKI) in CS. The oc-
currence of sepsis in patients with hypoalbuminemia has
a close pathophysiological relationship because the cor-
rect functioning of the immune response system de-
pends on the metabolic and nutritional status, and vice
versa [25]. Higher postoperative SAL may reflect a pre-
served lean body mass, which is related with nutritional
reserve and a more efficient metabolic state, leading to a
better inflammatory and immune response to surgery [2,
25]. On the other hand, sepsis is an important risk factor
for mortality after CS, which produces a sepsis-induced
cardiac dysfunction per se and preoperative hypoalbu-
minemia, has been shown to increase the risk for infec-
tion in CS [11].
Postoperative SAL may be useful as a predictive
tool because is affected by several factors related with
fluid and metabolic status [12]. Older age and smaller
BMI are considered risk factors for bleeding compli-
cations, which are also related to higher rates of poor
nutritional status [10, 11]. Indeed, in abdominal major
surgeries, albumin drop is related to bleeding and
major inflammatory response [26]. This may offer a
possible explanation for the association of higher rates
of sepsis and bleeding related complications, as well
as the higher mortality, with lower SAL subgroups in
our population.
We identified an association between chronic renal in-
sufficiency, past CS and longer CPB times, with the pres-
ence of mild to severe degree of hypoalbuminaemia at
24 h after CS. A high proportion of patients with the
need of a new CS suffer from heart failure, condition
which severity and prognosis is closely associated with
the presence of chronic inflammation and certain degree
of malnutrition [27]. Chronic renal insufficiency is also
associated with protein-energy wasting that leads to a
similar clinical scenario [28]. Both clinical conditions, es-
pecially in the presence of chronic renal insufficiency,
may be enhanced by SIRS caused by longer CPB times
[28–30]. In consequence, underlying causes of hypoalbu-
minemia may also influence worst outcomes in SAL
subgroups.
Administration of exogenous albumin in some critical
scenarios has proved to be a controversial measure across
different studies. In the case of sepsis and/or septic shock,
the latest researches state there is no influence over short-
term or long-term mortality and that its use may provide
a certain hemodynamic improvement with no effect in
survival rates [31]. On the contrary, a study proved that
the use of exogenous albumin has a protective effect over
the onset of AKI in patients with SAL < 40 g·L− 1 who
underwent CS [32]. These various range of results prove
the need to further analyze and research the use and de-
termination of albumin in critical care areas.
There are certain limitations to this study, such as
being a single-center long-term observational study,
increasing the risk of losing track in the follow-up of
Table 5 Differences between subgroups of patients with
different albumin levels 24 h after cardiac surgery
Odds ratio (95% CI) P value
Normal Levels (≥35 g·L−1) vs Low deficit (30–34.9 g·L−1)
In-hospital mortality 1.018 (1.002–1.034) 0.02
Normal Levels (≥35 g·L− 1) vs Mild deficit (25–29.9 g·L− 1)
Haemorrhage-related reexploration 2.549 (1.132–5.738) 0.02
Septicaemia 1.293 (1.145–1.459) 0.001
Mean ICU stay (hours) 1.778 (1.469–2.087) 0.04
In-hospital mortality 2.133 (1.019–3.259) 0.03
Normal Levels (≥35 g·L−1) vs Severe deficit (< 25 g·L− 1)
Haemorrhage-related reexploration 2.849 (2.132–3.138) 0.01
Septicaemia 2.025 (1.805–2.103) < 0.001
Mean ICU stay (hours) 2.045 (1.690–2.235) < 0.001
In-hospital mortality 3.206 (2.693–5.458) < 0.001
Low deficit (30–34.9 g·L− 1) vs Mild deficit (25–29.9 g·L− 1)
Haemorrhage-related reexploration 1.240 (1.122–1.350) 0.04
Low deficit (30–34.9 g·L− 1) vs Severe deficit (< 25 g·L− 1)
Haemorrhage-related reexploration 1.259 (0.094–0.715) 0.009
Septicaemia 1.035 (1.015–1.303) < 0.001
Mean ICU stay (hours) 2.580 (2.080–3.043) 0.011
In-hospital mortality 1.257 (1.103–1.624) 0.003
Mild deficit (25–29.9 g·L− 1) vs Severe deficit (< 25 g·L− 1)
Septicaemia 1.035 (1.015–1.303) < 0.001
In-hospital mortality 1.244 (1.130–1.456) < 0.001
Table 6 Multivariate analysis – dependent variable having
albumin levels < 30 g∙L− 1 24 h after cardiac surgery
Odds ratio (95% CI) P-value
Chronic renal insufficiency 1.316 (1.085–1.595) 0.005
Hemoglobin before surgery (g·dL− 1) 0.860 (0.633–1.088) 0.21
Past Cardiac surgery 1.229 (1.067–1.415) 0.004
Cardiopulmonary bypass time (> 100min) 1.904 (1.902–2.128) < 0.001
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some patients and the uncertainty over the causes of
death in some cases. We described our fluid resusci-
tation protocol in detail but the exact amount of fluid
challenge that could have influence postoperative SAL
has not been provided. On the other hand, it presents
several strengths. First, it is a prospective study in a
large tertiary referral hospital, with a high level of
complexity and a variety of all types of CS. In
addition, we showed a large sample size that was fur-
ther analyzed with systematic risk assessment, using
preoperative and postoperative scores. Our study
showed the importance of a proper stratification in
patients undergoing CS. In addition, we have shown
the risk profile of our CS population that may allow
future comparisons with other series of CS patients,
which is of great importance since the widespread use
and importance of risk score stratification [15, 33].
We think it would have been interesting to check
SAL several times after CS in order to provide better
understanding about their behavior. However, this is
beyond the scope and the aims of the present
research.
Conclusions
In summary, our study showed that the occurrence and
the degree of hypoalbuminemia in the postoperative of
CS is frequent and it may be associated with the devel-
opment of several complications (especially septic or
bleeding-related) and worst outcomes, even in long-term
survival. Nutritional and inflammatory factors may be
associated with the development of postoperative hypo-
albuminemia. Postoperative SAL and factors associated
with the development of mild to severe postoperative
hypoalbuminemia may serve to early identify patients at
risk of worst outcomes, which may ultimately help to in-
tensity their monitoring and care in order to improve
their status.
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